Kevin Ni

Internal Medicine physician (MDPhD IUSM, AB Harvard) passionate about endocrine, diabetes, primary care, diverse communities, research & teaching.

[Kevin Ni @KevinChenNi]

Match Day this Friday and graduation in 2 months. Todos entramos a la residencia médica! Andale pues! @MaritzaGomezMEd @Guadalupe_J1 @juandvaldes @Atorres113 @ItsMarielLuna @AdolfoJBaez1 @ManuGilCupello @LieblRebeca @IUMedSchool

[Kevin Ni @KevinChenNi]

Found my PhD committee again (Dr. Evans-Molina) #ADA2025
@CUEndocrinology

[Kevin Ni @KevinChenNi]

Found my phd committee (Dr. Dong) and meeting rockstar endo fellows at ADA 2025. @ayekhineMD @CUEndocrinology

[Kevin Ni @KevinChenNi]

ADA Scholars 2025 with Jane Reusch! @CUEndocrinology @ADA_DiabetesPro

[Kevin Ni @KevinChenNi]

@Cervantes_Lily1 @translatedmed Congrats Jorge!

[Kevin Ni @KevinChenNi]

To conclude June (MensHealthMonth), Drs. Harroun, Ni, and Doolan with CU Internal Medicine shared general health/diet/lifestyle tips.
@CUEndocrinology
@CUInternalMed https://t.co/1xUMXliWB4

[Kevin Ni @KevinChenNi]

@Cervantes_Lily1 @AnnaGaddy I discussed wanting to work with Dr. Cervantes when I interviewed for primary care-track so this was a dream come true.

[Lilia Cervantes @Cervantes_Lily1]

New📜led by @KevinChenNi -- In this study, Kevin conducted qualitative interviews of racially and ethnically diverse low-income individuals with diabetes who became eligible for continuous glucose monitoring (CGM) -- highlights the importance of health policy change that expands access to CGM to the people that actually need them.

[Kevin Ni @KevinChenNi]

Our follow-up qualitative study of FQHC primary care patients with type 2 diabetes establishes CGM as a patient-centered tool for mitigating diabetes disparities in socially minoritized and marginalized populations. @CUEndocrinology @CUDeptMedicine https://t.co/9yo0ebbd4H

[Aaron Neinstein, MD @AaronNeinstein]

Very important paper published in Diabetes Care, looking at #cgm uptake in Medicaid patients with #diabetes, when CGM was fully subsidized irrespective of T1D or T2D. The paper shows no diff in CGM fill rate and A1c outcomes between groups. (1/n) https://t.co/GZYwSrWDmc

[Kevin Ni @KevinChenNi]

Our qualitative study "Continuous glucose monitor: reclaiming type 2 diabetes self-efficacy and mitigating disparities" was published in JES. @KayceSol @ctampe @Cervantes_Lily1 @RocioPereiraMD1 @CUEndocrinology @CUInternalMed https://t.co/9yo0ebbKUf

[Kevin Ni @KevinChenNi]

Charles canoeing. Paddling or notepadding? #ENDO2024

[CU Anschutz Endocrinology @CUEndocrinology]

Medicine resident Dr Kevin Ni presented his work at the health disparities poster session at #ENDO2024.
@CUDeptMedicine @CUInternalMed

[Kevin Ni @KevinChenNi]

Colorado residents+fellow! #ENDO2024 @CUEndocrinology

[Kevin Ni @KevinChenNi]

@DrEEverett1 @dgsomucla @UCLA_GIMHSR @DOM_UCLA Congrats Walter! Echale!

[Kevin Ni @KevinChenNi]

Dos candidatas y la primera mujer presidenta de mexico! ¡Echale!

[Claudia Sheinbaum Pardo @Claudiashein]

Gracias, gracias, gracias; no les voy a fallar. Vamos a avanzar con el Segundo Piso de la Cuarta Transformación.

[Kevin Ni @KevinChenNi]

Thyroid plushy & notepad courtesy of Endo Mentor Day @TheEndoSociety

[Kevin Ni @KevinChenNi]

Future endocrinologist? #ENDO2024

[Kevin Ni @KevinChenNi]

Health disparities poster preview presenters! #endo2024
@CUEndocrinology
photo credits
@AnaRivadeneira0

[Daniel J Drucker @DanielJDrucker]

“Because SGLT2 inhibitors and nonsteroidal MRAs had not been approved for kidney protection at the time the trial was initiated, the number of participants who were receiving these agents at baseline was modest, which limited our ability to assess the effects of combination Rx”

[Vin Tangpricha, MD, PhD @vtangpricha]

Dr Low Wang presents on insulins in patients on enteral nutrition #AACE2024 #EndocrinePractice

[Casa Presidencial 🇸🇻 @PresidenciaSV]

Esta tarde, el Presidente Electo @nayibbukele se encuentra inaugurando las nuevas oficinas de @Google en El Salvador. 🇸🇻